Trial Profile
Retrospective cohort study investigating safety and efficacy of once-daily maraviroc plus ritonavir-boosted darunavir in pre-treated HIV patients in a real-life setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Darunavir/ritonavir (Primary) ; Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 17 Dec 2015 New trial record